Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CLB
stocks logo

CLB

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Financial AI Agent
Financial AI Agent

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
130.40M
+0.9%
0.185
-15.91%
125.40M
+1.47%
0.150
+7.14%
130.60M
+0.33%
0.185
-2.63%
Estimates Revision
The market is revising Upward the revenue expectations for Core Laboratories Inc. (CLB) for FY2025, with the revenue forecasts being adjusted by 0.46% over the past three months. During the same period, the stock price has changed by 30.67%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.46%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-4.42%
In Past 3 Month
Stock Price
Go Up
up Image
+30.67%
In Past 3 Month
Wall Street analysts forecast CLB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLB is 12.00 USD with a low forecast of 12.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast CLB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLB is 12.00 USD with a low forecast of 12.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
1 Hold
1 Sell
Moderate Sell
Current: 16.490
sliders
Low
12.00
Averages
12.00
High
12.00
Current: 16.490
sliders
Low
12.00
Averages
12.00
High
12.00
Stifel
Hold
downgrade
$13 -> $12
2025-07-16
Reason
Stifel
Price Target
$13 -> $12
2025-07-16
downgrade
Hold
Reason
Stifel lowered the firm's price target on Core Laboratories to $12 from $13 and keeps a Hold rating on the shares. Oil service stocks have underperformed the S&P 500 in 2025, and catalysts have been largely negative, the analyst tells investors in a research note. Entering Q2 earnings season, the firm believes shares will be range bound until estimates stop falling.
Citi
Neutral
downgrade
$16 -> $13
2025-05-13
Reason
Citi
Price Target
$16 -> $13
2025-05-13
downgrade
Neutral
Reason
Citi lowered the firm's price target on Core Laboratories to $13 from $16 and keeps a Neutral rating on the shares. The firm updated models for a collection of Smid-cap oil and gas equipment and services stocks to incorporate updated rig count forecasts and recent earnings.
Stifel
Stephen Gengaro
Hold
downgrade
$15 -> $13
2025-04-25
Reason
Stifel
Stephen Gengaro
Price Target
$15 -> $13
2025-04-25
downgrade
Hold
Reason
Stifel analyst Stephen Gengaro lowered the firm's price target on Core Laboratories to $13 from $15 and keeps a Hold rating on the shares after the company delivered "mixed" Q1 results. Growth in Production Enhancement was offset by sluggish Reservoir Description performance, says the firm, which expects second half results to be similar to the first half due to macro uncertainty, tariffs, and oil prices.
Stifel
Stephen Gengaro
Hold
Maintains
$19 → $15
2025-04-15
Reason
Stifel
Stephen Gengaro
Price Target
$19 → $15
2025-04-15
Maintains
Hold
Reason
Citigroup
Scott Gruber
Strong Sell
to
Hold
Upgrades
$15 → $16
2025-03-12
Reason
Citigroup
Scott Gruber
Price Target
$15 → $16
2025-03-12
Upgrades
Strong Sell
to
Hold
Reason
Citigroup
Scott Gruber
Strong Sell
Maintains
$14 → $15
2025-02-20
Reason
Citigroup
Scott Gruber
Price Target
$14 → $15
2025-02-20
Maintains
Strong Sell
Reason
Citi raised the firm's price target on Core Laboratories to $15 from $14 and keeps a Sell rating on the shares. The firm updated the company's model post the earnings report.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Core Laboratories Inc (CLB.N) is 22.28, compared to its 5-year average forward P/E of 26.62. For a more detailed relative valuation and DCF analysis to assess Core Laboratories Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
26.62
Current PE
22.28
Overvalued PE
37.21
Undervalued PE
16.03

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
15.79
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
20.82
Undervalued EV/EBITDA
10.77

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.97
Current PS
0.00
Overvalued PS
2.66
Undervalued PS
1.29
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

CLB News & Events

Events Timeline

(ET)
2025-10-22
17:03:14
Core Laboratories Announces Q3 Earnings Per Share of 30 Cents, Exceeding Estimates of 19 Cents
select
2025-09-30 (ET)
2025-09-30
16:18:17
Core Laboratories purchases geological services firm Solintec
select
2025-07-23 (ET)
2025-07-23
17:19:07
Core Laboratories sees Q3 EPS 18c-22c vs. 25c last year
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
07-29NASDAQ.COM
Core Labs Posts Flat Revenue in Q2

  • Q2 2025 Financial Performance: Core Laboratories reported Q2 2025 revenue of $130.2 million, slightly exceeding expectations but flat year-over-year, with adjusted EPS at $0.19, reflecting a 13.6% decline from the previous year. The company emphasized operational progress in international markets and maintained a focus on technological innovation and cost management.

  • Future Outlook and Risks: For Q3 2025, Core Laboratories forecasts revenue between $127.5 million and $134.5 million, with potential risks stemming from oil and gas industry cycles, U.S. market unpredictability, and tariffs affecting production materials. The company plans to maintain its dividend at $0.01 per share while prioritizing free cash generation and reinvestment in technology.

[object Object]
Preview
3.0
07-18NASDAQ.COM
Core Laboratories to Post Q2 Earnings: Key Metrics to Watch

  • Earnings Report Overview: Core Laboratories Inc. (CLB) is set to release its second-quarter 2025 results on July 23, with expectations of an 18-cent profit per share and revenues of $129.3 million, reflecting a year-over-year decline in both earnings and revenues due to weak performance in its Reservoir Description and Production Enhancement segments.

  • Market Position and Predictions: CLB's recent performance has been mixed, missing earnings estimates in two of the last four quarters and currently holding a Zacks Rank #5 (Strong Sell), indicating challenges ahead, while other companies in the energy sector like Ovintiv, TotalEnergies, and Hess show more favorable earnings prospects.

[object Object]
Preview
4.0
07-16Benzinga
Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $12

  • Real-time Intelligence for Traders: Benzinga Pro offers the fastest news alerts and exclusive stories to help traders succeed in the stock market.

  • Community of Serious Traders: Over 10,000 traders are part of the Benzinga Pro community, benefiting from accurate market intelligence and insights.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Core Laboratories Inc (CLB) stock price today?

The current price of CLB is 16.49 USD — it has increased 0.43 % in the last trading day.

arrow icon

What is Core Laboratories Inc (CLB)'s business?

Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects.

arrow icon

What is the price predicton of CLB Stock?

Wall Street analysts forecast CLB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLB is 12.00 USD with a low forecast of 12.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Core Laboratories Inc (CLB)'s revenue for the last quarter?

Core Laboratories Inc revenue for the last quarter amounts to 134.52M USD, increased 0.09 % YoY.

arrow icon

What is Core Laboratories Inc (CLB)'s earnings per share (EPS) for the last quarter?

Core Laboratories Inc. EPS for the last quarter amounts to 0.30 USD, increased 20.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Core Laboratories Inc (CLB)'s fundamentals?

The market is revising Upward the revenue expectations for Core Laboratories Inc. (CLB) for FY2025, with the revenue forecasts being adjusted by 0.46% over the past three months. During the same period, the stock price has changed by 30.67%.
arrow icon

How many employees does Core Laboratories Inc (CLB). have?

Core Laboratories Inc (CLB) has 3500 emplpoyees as of December 05 2025.

arrow icon

What is Core Laboratories Inc (CLB) market cap?

Today CLB has the market capitalization of 767.60M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free